ELEV
Millennium Management’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
+1,424,446
| New | +$523K | ﹤0.01% | 3345 |
|
|
2025
Q1 | – | Sell |
-815,916
| Closed | -$459K | – | 4075 |
|
|
2024
Q4 | $459K | Buy |
815,916
+30,466
| +4% | +$17.1K | ﹤0.01% | 3324 |
|
|
2024
Q3 | $471K | Buy |
+785,450
| New | +$471K | ﹤0.01% | 3334 |
|
|
2024
Q2 | – | Sell |
-668,573
| Closed | -$3.43M | – | 4085 |
|
|
2024
Q1 | $3.43M | Sell |
668,573
-2,321,706
| -78% | -$11.9M | ﹤0.01% | 2260 |
|
|
2023
Q4 | $1.61M | Sell |
2,990,279
-41,935
| -1% | -$22.5K | ﹤0.01% | 2576 |
|
|
2023
Q3 | $2.01M | Buy |
3,032,214
+715,788
| +31% | +$474K | ﹤0.01% | 2464 |
|
|
2023
Q2 | $3.52M | Buy |
+2,316,426
| New | +$3.52M | ﹤0.01% | 2164 |
|
|
2022
Q3 | – | Sell |
-21,573
| Closed | -$30K | – | 5232 |
|
|
2022
Q2 | $30K | Buy |
+21,573
| New | +$30K | ﹤0.01% | 4894 |
|
|
2022
Q1 | – | Sell |
-10,463
| Closed | -$63K | – | 5267 |
|
|
2021
Q4 | $63K | Buy |
+10,463
| New | +$63K | ﹤0.01% | 4956 |
|
|
2021
Q3 | – | Sell |
-123,062
| Closed | -$1.67M | – | 5187 |
|
|
2021
Q2 | $1.67M | Buy |
+123,062
| New | +$1.67M | ﹤0.01% | 3316 |
|